Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation. [electronic resource]
- British journal of clinical pharmacology Jul 2007
- 110-2 p. digital
Publication Type: Comment; Letter
0306-5251
10.1111/j.1365-2125.2006.02840.x doi
Anti-Bacterial Agents--therapeutic use Antineoplastic Agents, Phytogenic--therapeutic use Coronary Thrombosis Humans Paclitaxel--therapeutic use Risk Factors Sirolimus--therapeutic use Stents